Foresight Group Ltd Liability Partnership Sells 88,666 Shares of Healthpeak Properties, Inc. $DOC

Foresight Group Ltd Liability Partnership decreased its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 7.3% in the 1st quarter, Holdings Channel.com reports. The firm owned 1,130,722 shares of the real estate investment trust’s stock after selling 88,666 shares during the period. Healthpeak Properties makes up 3.3% of Foresight Group Ltd Liability Partnership’s investment portfolio, making the stock its 13th largest position. Foresight Group Ltd Liability Partnership’s holdings in Healthpeak Properties were worth $22,828,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of DOC. Machina Capital S.A.S. grew its stake in Healthpeak Properties by 62.8% in the 1st quarter. Machina Capital S.A.S. now owns 37,160 shares of the real estate investment trust’s stock valued at $751,000 after buying an additional 14,336 shares in the last quarter. Douglas Lane & Associates LLC lifted its position in shares of Healthpeak Properties by 8.5% during the first quarter. Douglas Lane & Associates LLC now owns 2,792,850 shares of the real estate investment trust’s stock worth $56,471,000 after acquiring an additional 218,395 shares in the last quarter. Cambridge Investment Research Advisors Inc. boosted its holdings in shares of Healthpeak Properties by 6.9% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 357,520 shares of the real estate investment trust’s stock worth $7,229,000 after acquiring an additional 23,135 shares during the period. Ibex Wealth Advisors purchased a new position in shares of Healthpeak Properties in the first quarter valued at $5,056,000. Finally, Vert Asset Management LLC raised its stake in shares of Healthpeak Properties by 6.9% during the 1st quarter. Vert Asset Management LLC now owns 325,143 shares of the real estate investment trust’s stock valued at $6,574,000 after purchasing an additional 20,924 shares during the period. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

DOC has been the topic of several analyst reports. Morgan Stanley decreased their price target on Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating on the stock in a research report on Friday, August 22nd. Wall Street Zen downgraded shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Monday, July 7th. Robert W. Baird set a $21.00 price target on shares of Healthpeak Properties and gave the stock an “outperform” rating in a report on Wednesday, July 30th. Scotiabank downgraded Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and lowered their price objective for the stock from $21.00 to $19.00 in a research report on Tuesday, July 29th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $18.00 price objective (down previously from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Seven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $21.50.

Healthpeak Properties Price Performance

DOC stock opened at $17.97 on Thursday. The firm has a 50 day simple moving average of $17.76 and a two-hundred day simple moving average of $18.22. The stock has a market cap of $12.48 billion, a PE ratio of 74.86, a P/E/G ratio of 2.32 and a beta of 1.07. Healthpeak Properties, Inc. has a one year low of $16.63 and a one year high of $23.26. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The firm had revenue of $694.35 million for the quarter, compared to analysts’ expectations of $697.14 million. During the same quarter last year, the company posted $0.45 EPS. The business’s quarterly revenue was down .2% on a year-over-year basis. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently declared a monthly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 18th were given a dividend of $0.1017 per share. The ex-dividend date was Monday, August 18th. This represents a c) dividend on an annualized basis and a yield of 6.8%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 508.33%.

Insider Transactions at Healthpeak Properties

In other news, CEO Scott M. Brinker acquired 1,490 shares of the business’s stock in a transaction dated Monday, August 4th. The stock was purchased at an average cost of $16.83 per share, for a total transaction of $25,076.70. Following the acquisition, the chief executive officer owned 211,906 shares of the company’s stock, valued at $3,566,377.98. This trade represents a 0.71% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders bought a total of 8,783 shares of company stock worth $150,129 over the last three months. Insiders own 0.23% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.